We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+676.14%
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
-$15.6B
Cap. Flow %
-1.8%
Top 10 Hldgs %
34.38%
Holding
3,202
New
115
Increased
2,022
Reduced
804
Closed
71

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$1.82B
2
SE icon
Sea Limited
SE
+$1.38B
3
CSCO icon
Cisco
CSCO
+$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.54B
2
AMZN icon
Amazon
AMZN
+$1.75B
3
APH icon
Amphenol
APH
+$1.65B
4
KLAC icon
KLA
KLAC
+$1.5B
5
XEL icon
Xcel Energy
XEL
+$1.38B

Sector Composition

Rank Sector Weight
1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLS
1201
DELISTED
Chart Industries
GTLS
$10.5M ﹤0.01%
50,607
+7,629
+18% +$1.58M
BEN icon
1202
Franklin Resources
BEN
$17.3B
$10.4M ﹤0.01%
439,291
-5,190
-1% -$134K
PAAS icon
1203
Pan American Silver
PAAS
$18.6B
$10.4M ﹤0.01%
+189,846
New +$10.9M
EIKN
1204
Eikon Therapeutics
EIKN
$535M
$10.3M ﹤0.01%
+975,834
New +$13M
EXEL icon
1205
Exelixis
EXEL
$14B
$10.3M ﹤0.01%
240,182
+23,765
+11% +$1.02M
TAP icon
1206
Molson Coors Class B
TAP
$7.71B
$10.2M ﹤0.01%
237,580
-3,366
-1% -$160K
POOL icon
1207
Pool Corp
POOL
$6.73B
$10.2M ﹤0.01%
50,276
-65,174
-56% -$15.4M
ALLY icon
1208
Ally Financial
ALLY
$13.3B
$10.1M ﹤0.01%
258,539
+25,566
+11% +$1.05M
AGIO icon
1209
Agios Pharmaceuticals
AGIO
$2.2B
$10.1M ﹤0.01%
298,783
-339,103
-53% -$9.61M
NEWT icon
1210
NewtekOne
NEWT
$415M
$10.1M ﹤0.01%
922,469
+565,363
+158% +$7.17M
BL icon
1211
BlackLine
BL
$1.8B
$10.1M ﹤0.01%
271,844
+9,033
+3% +$389K
QLYS icon
1212
Qualys
QLYS
$4.75B
$9.99M ﹤0.01%
113,677
-65,879
-37% -$7.3M
BMRN icon
1213
BioMarin Pharmaceuticals
BMRN
$11.6B
$9.96M ﹤0.01%
176,275
+18,696
+12% +$1.09M
THR
1214
DELISTED
Thermon Group Holdings
THR
$9.86M ﹤0.01%
195,526
+19,044
+11% +$888K
TRIN icon
1215
Trinity Capital
TRIN
$1.56B
$9.83M ﹤0.01%
668,126
+123,079
+23% +$1.9M
FHN icon
1216
First Horizon
FHN
$12.1B
$9.81M ﹤0.01%
431,200
+24,903
+6% +$596K
OGE icon
1217
OGE Energy
OGE
$10.2B
$9.79M ﹤0.01%
204,063
+24,694
+14% +$1.13M
HRL icon
1218
Hormel Foods
HRL
$14.3B
$9.75M ﹤0.01%
430,340
-5,008
-1% -$120K
UFPI icon
1219
UFP Industries
UFPI
$4.98B
$9.75M ﹤0.01%
105,787
+19,442
+23% +$1.97M
AGNC icon
1220
AGNC Investment
AGNC
$12.4B
$9.64M ﹤0.01%
961,462
+142,779
+17% +$1.58M
IMRX icon
1221
Immuneering
IMRX
$282M
$9.64M ﹤0.01%
1,829,188
-164,770
-8% -$845K
BAM icon
1222
Brookfield Asset Management
BAM
$75.9B
$9.62M ﹤0.01%
216,280
+23,188
+12% +$1.13M
PHIN icon
1223
Phinia Inc
PHIN
$2.91B
$9.61M ﹤0.01%
140,408
+15,385
+12% +$1.07M
ERIE icon
1224
Erie Indemnity
ERIE
$11.9B
$9.46M ﹤0.01%
37,627
-427
-1% -$115K
POST icon
1225
Post Holdings
POST
$4.14B
$9.44M ﹤0.01%
95,511
+54,218
+131% +$5.52M

Similar funds

T. Rowe Price Associates's Q1 2026 Portfolio in Review

As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.

  • T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
  • T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
  • T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
  • T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
  • T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
  • T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
  • T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.